News

The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...
There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...
Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, which provides the opportunity for Moderna scientists to explore how to apply quantum computing toward the development ...
Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are excited ...
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...
Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discovery of mRNA medicines.
The biotechnology and pharmaceutical firm Moderna Inc., best known for its COVID-19 vaccine, said today it’s working with IBM Corp. to explore ways in which quantum computing and generative artifici ...
Through the partnership, Moderna will have access to IBM’s quantum computers. Additionally, Moderna and IBM scientists will use the MoLFormer AI model to help predict molecules’ properties and ...
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM) today announced an agreement under which Moderna will explore ...
CAMBRIDGE, MA and ARMONK, NY / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM ...
CAMBRIDGE, MA and ARMONK, NY / April 20, 2023 / Moderna, Inc. (Nasdaq: MRNA), a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE: IBM) have announced an ...
Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.